Investor Soleus Private Equity Fund I, L.P.
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Soleus Private Equity Fund I, L.P. . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2024-11-14 13G/A NPCE / NeuroPace, Inc. 2,432,768 2,433,168
2024-10-02 13D/A BCAB / BioAtla, Inc. 2,648,472 1,237,909
2024-09-06 13D/A BCAB / BioAtla, Inc. 3,901,314 2,648,472
2024-04-16 13D/A BCAB / BioAtla, Inc. 4,220,397 3,901,314
2024-02-02 13G/A NPCE / NeuroPace, Inc. 2,369,003 2,432,768
2023-02-14 13G/A NPCE / NeuroPace, Inc. 2,309,003 2,369,003
2023-01-09 13D/A BCAB / BioAtla, Inc. 2,247,524 4,220,397
2022-02-10 13G/A GLTO / Galecto, Inc. 1,512,648 0
2022-02-10 13G/A NPCE / NeuroPace, Inc. 1,835,340 2,309,003
2021-11-01 13G NPCE / NeuroPace, Inc. 1,835,340
2021-09-03 13D/A BCAB / BioAtla, Inc. 2,794,233 2,247,524
2021-06-28 13D/A BCAB / BioAtla, Inc. 3,194,233 2,794,233
2021-02-12 13G/A GLTO / Galecto, Inc. 1,518,048 1,512,648
2020-12-28 13D BCAB / BioAtla, Inc. 3,194,233
2020-11-12 13G GLTO / Galecto, Inc. 1,518,048